Ginkgo Bioworks partners with WARF for new GD2 CAR T-cell therapies
Pharmaceutical Technology
APRIL 14, 2023
Ginkgo Bioworks (Ginkgo) and the Wisconsin Alumni Research Foundation (WARF) have collaborated to discover next-generation GD2 CAR T-cell therapies to treat solid tumours. WARF is the patenting and licensing organisation for the University of Wisconsin–Madison in the US.
Let's personalize your content